1. Home
  2. DCTH vs GHG Comparison

DCTH vs GHG Comparison

Compare DCTH & GHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

DCTH

Delcath Systems Inc.

N/A

Current Price

$16.99

Market Cap

578.4M

Sector

Health Care

ML Signal

N/A

GHG

GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

HOLD

Current Price

$1.08

Market Cap

116.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
DCTH
GHG
Founded
1988
2004
Country
United States
China
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Hotels/Resorts
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
578.4M
116.0M
IPO Year
2015
2017

Fundamental Metrics

Financial Performance
Metric
DCTH
GHG
Price
$16.99
$1.08
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$22.00
N/A
AVG Volume (30 Days)
690.5K
7.2K
Earning Date
05-07-2026
04-29-2026
Dividend Yield
N/A
4.15%
EPS Growth
107.53
N/A
EPS
0.04
N/A
Revenue
N/A
N/A
Revenue This Year
$24.54
$19.02
Revenue Next Year
$33.15
$8.26
P/E Ratio
$418.75
$5.76
Revenue Growth
N/A
N/A
52 Week Low
$8.12
$1.08
52 Week High
$17.42
$2.57

Technical Indicators

Market Signals
Indicator
DCTH
GHG
Relative Strength Index (RSI) 67.14 45.12
Support Level $10.16 $1.10
Resistance Level $17.42 $1.16
Average True Range (ATR) 0.80 0.02
MACD 0.12 -0.00
Stochastic Oscillator 90.38 37.50

Price Performance

Historical Comparison
DCTH
GHG

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The Group reports its financial results in two operating segments: Hotel Business, which consists of leased-and-operated hotels and franchised-and-managed hotels operating under the hotel related brand, and Restaurant Business, which consists of leased-and-operated restaurants and franchised-and-managed restaurants operating under the brands of Da Niang and Bellagio. It derives maximum revenue from Hotel Business segment. It operates solely in China and generates all its revenue from China itself.

Share on Social Networks: